Evidence map›Paper›PMID 36607390›Full record

Observational studyWorld journal of surgery2023

Time to Treatment Initiation for Six Cancer Types: An Analysis of Data from a Nationwide Registry in Japan.

Tomone Watanabe, Ryoko Rikitake, Tamaki Kakuwa, Yuichi Ichinose, Mariko Niino, Yu Mizushima, Masato Ota, Manami Fujishita, Yoichiro Tsukada, Takahiro Higashi

Abstract readObservational Study
In one paragraph

Observational study in World journal of surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomone WatanabeDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Ryoko RikitakeDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan. rrikitak@ncc.go.jp.ORCID 0000-0002-0232-8283
Tamaki KakuwaDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Yuichi IchinoseDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Mariko NiinoDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Yu MizushimaDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Masato OtaDepartment of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Manami FujishitaDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Yoichiro TsukadaDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.
Takahiro HigashiDivision of Health Services Research, Institute for Cancer Control, National Cancer Center, 5-1-1Tsukiji, , Chuo-Ku, Tokyo, 104-0045, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelay in the time to treatment initiation (TTI) may adversely affect the survival of patients, but its current status in Japan is unknown. This study aims to describe the TTI for six cancer types: lung, breast, colorectal, stomach, head and neck (H&N), and cervical. Data for this study were derived from a nationwide registry in Japan.

methodsThis observational study employed the national database of hospital-based cancer registries (HBCRs) and health services utilization data. Using HBCR data, we identified all patients with cancer who started their cancer therapy at the same hospitals between January 1 and December 31, 2017. We calculated the TTI for each cancer type and treatment option, stratifying the results by age group and geographical region.

resultsThe overall median TTI was 33 days, with shorter TTIs for colorectal and H&N cancers and chemotherapy. The TTI was the shortest for younger patients and the longest for the elderly, especially for lung cancer. When categorized by eight Japanese geographical regions, Tohoku and Kanto had the longest TTI. The result remained the same even after adjusting cancer type, treatment, age, and stage information.

conclusionFor colorectal and H&N cancers, in which a longer TTI is associated with a poorer prognosis, TTI was found to be particularly shorter. Although we could not discuss our results in light of the patient survival in this study, future research should explore the best balance between thorough evaluation before treatment and necessary time for that.

Indexed as

Colorectal NeoplasmsHead and Neck NeoplasmsAgedHumansJapanRegistriesTime-to-Treatment

Identifiers

PMID36607390
PMCPMC9821366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.